<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta content="text/html; charset=utf-8" http-equiv="Content-Type"/><title>
</title>
<style type="text/css">
			.cs2E86D3A6{text-align:center;text-indent:0pt;margin:0pt 0pt 0pt 0pt}
			.cs5925EB86{color:#000000;background-color:transparent;font-family:'Century Schoolbook';font-size:10pt;font-weight:bold;font-style:normal;}
			.cs95E872D0{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt}
			.csDD5E5F52{color:#000000;background-color:transparent;font-family:'Century Schoolbook';font-size:10pt;font-weight:normal;font-style:normal;}
			.csED7826F6{color:#000000;background-color:transparent;font-family:'Century Schoolbook';font-size:14pt;font-weight:bold;font-style:italic;}
			.csE0B838BE{text-align:justify;text-indent:-86pt;margin:0pt 0pt 0pt 86pt}
			.csA16174BA{color:#000000;background-color:transparent;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;}
			.cs9224F58F{text-align:justify;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:12pt;mso-line-height-rule:exactly}
			.csC970676{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:12pt;mso-line-height-rule:exactly}
			.cs5ADD8C59{color:#000000;background-color:transparent;font-family:'Century Schoolbook';font-size:9pt;font-weight:normal;font-style:normal;}
			.csE2DB38B2{color:#000000;background-color:transparent;font-family:'Century Schoolbook';font-size:9pt;font-weight:bold;font-style:italic;}
			.cs5D3E032C{color:#000000;background-color:transparent;font-family:'Century Schoolbook';font-size:9pt;font-weight:normal;font-style:normal;text-decoration: line-through;}
			.cs41ED3027{text-align:center;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:12pt;mso-line-height-rule:exactly}
			.csE3E0FE0B{color:#000000;background-color:transparent;font-family:'Century Schoolbook';font-size:10pt;font-weight:normal;font-style:italic;}
			.cs5CA3ADAD{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 54pt;line-height:12pt;mso-line-height-rule:exactly}
			.csF0A1D375{text-align:justify;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:1.5}
			.cs22FF6315{color:#000000;background-color:transparent;font-family:'Century Schoolbook';font-size:10pt;font-weight:bold;font-style:italic;}
			.cs98AF35F2{color:#000000;background-color:transparent;font-family:'Century Schoolbook';font-size:10pt;font-weight:normal;font-style:normal;text-decoration: line-through;}
			.cs2C11128C{color:#000000;background-color:transparent;font-family:'Century Schoolbook';font-size:12pt;font-weight:normal;font-style:normal;}
		</style>
</head>
<body>
<p class="cs2E86D3A6"><span class="cs5925EB86">SB 45  - AS INTRODUCED</span></p><p class="cs2E86D3A6"><span class="cs5925EB86"> </span></p><p class="cs95E872D0"><span class="csDD5E5F52"> </span></p><p class="cs2E86D3A6"><span class="csDD5E5F52">2021 SESSION</span></p><p class="cs95E872D0" style="tab-stops:left 396pt;"><span class="csDD5E5F52">	21-0834</span></p><p class="cs95E872D0" style="tab-stops:left 396pt;"><span class="csDD5E5F52">	10/05</span></p><p class="cs95E872D0"><span class="csDD5E5F52"> </span></p><p class="cs95E872D0" style="tab-stops:left 108pt;"><span class="csDD5E5F52">SENATE BILL	</span><span class="csED7826F6">45</span></p><p class="cs95E872D0"><span class="csDD5E5F52"> </span></p><p class="csE0B838BE"><span class="csDD5E5F52">AN ACT	</span><a name="bkTitleDraft0"><span class="csDD5E5F52">relative to the controlled drug prescription health and safety program.</span></a></p><p class="cs95E872D0"><span class="csDD5E5F52"> </span></p><p class="csE0B838BE" style="tab-stops:left 86.45pt;"><span class="csDD5E5F52">SPONSORS:	Sen. Giuda, Dist 2; Sen. Soucy, Dist 18; Sen. Carson, Dist 14; Sen. Prentiss, Dist 5; Rep. M. Pearson, Rock. 34; Rep. Marsh, Carr. 8; Rep. Merchant, Sull. 4</span></p><p class="cs95E872D0"><span class="csDD5E5F52"> </span></p><p class="csE0B838BE" style="tab-stops:left 86.45pt;"><span class="csDD5E5F52">COMMITTEE:	Health and Human Services</span></p><p class="cs95E872D0" style="tab-stops:left 90pt;"><span class="csDD5E5F52"> </span></p><p class="cs95E872D0" style="tab-stops:left 90pt;"><span class="csA16174BA">-----------------------------------------------------------------</span></p><p class="cs95E872D0" style="tab-stops:left 90pt;"><span class="csDD5E5F52"> </span></p><p class="cs2E86D3A6"><span class="csDD5E5F52">ANALYSIS</span></p><p class="cs95E872D0"><span class="csDD5E5F52"> </span></p><p class="cs9224F58F" style="tab-stops:left 18pt left 86.45pt;"><span class="csDD5E5F52">	This bill authorizes the department of health and human services to access certain data and information from the controlled drug prescription health and safety program under certain circumstances.</span></p><p class="cs95E872D0"><span class="csDD5E5F52"> </span></p><p class="cs95E872D0"><span class="csDD5E5F52">- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - </span></p><p class="cs95E872D0"><span class="csDD5E5F52"> </span></p><p class="csC970676" style="tab-stops:left 14.4pt left 82.8pt;"><span class="cs5ADD8C59">Explanation:	Matter added to current law appears in </span><span class="csE2DB38B2">bold italics.</span></p><p class="csC970676" style="tab-stops:left 14.4pt left 82.8pt;"><span class="cs5ADD8C59">		Matter removed from current law appears [</span><span class="cs5D3E032C">in brackets and struckthrough.</span><span class="cs5ADD8C59">]</span></p><p class="csC970676" style="tab-stops:left 14.4pt left 82.8pt;"><span class="cs5ADD8C59">		Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.</span></p><p class="csC970676" style="tab-stops:left 396pt;"><span class="csDD5E5F52">	21-0834</span></p><p class="csC970676" style="tab-stops:left 396pt;"><span class="csDD5E5F52">	10/05</span></p><p class="cs95E872D0"><span class="csDD5E5F52"> </span></p><p class="cs41ED3027" style="tab-stops:left 396pt;"><span class="csDD5E5F52">STATE OF NEW HAMPSHIRE</span></p><p class="cs41ED3027" style="tab-stops:left 396pt;"><span class="csDD5E5F52"> </span></p><p class="cs41ED3027" style="tab-stops:left 396pt;"><span class="csE3E0FE0B">In the Year of Our Lord Two Thousand Twenty One</span></p><p class="csC970676" style="tab-stops:left 396pt;"><span class="csDD5E5F52"> </span></p><p class="csE0B838BE"><span class="csDD5E5F52">AN ACT	</span><a name="_dx_frag_StartFragment"></a><a name="_dx_frag_EndFragment"></a><a name="bkTitleDraft1"><span class="csDD5E5F52">relative to the controlled drug prescription health and safety program.</span></a></p><p class="cs5CA3ADAD" style="tab-stops:left 396pt;"><span class="csDD5E5F52"> </span></p><p class="cs41ED3027" style="tab-stops:left 396pt;"><span class="csE3E0FE0B">Be it Enacted by the Senate and House of Representatives in General Court convened:</span></p><p class="cs41ED3027" style="tab-stops:left 396pt;"><span class="csDD5E5F52"> </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52"> </span><a name="Chapt1"></a><span class="csDD5E5F52">1  Statement of Intent.  The purpose and intent of this legislation is to improve the health and wellbeing of New Hampshire citizens by authorizing meaningful access by the department of health and human services to data, including identifiable patient-level data or information, from the office of professional licensure and certification, controlled drug prescription health and safety program, for public health purposes including, but not limited to, public health evaluation, coordination of health care, and for the delivery of critical services to address substance use disorders.</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52"> </span><a name="Chapt2"></a><span class="csDD5E5F52">2  New Section; Department of Health and Human Services; Controlled Drug Prescription Health and Safety Program Information; Confidentiality.  Amend RSA 126-A by inserting after section 5-e the following new section:</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">	126-A:5-f  Controlled Drug Prescription Health and Safety Program; Confidentiality.</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">		I.  In this section "office" means the office of professional licensure and certification, established in RSA 310-A. </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">		II.  Information and data obtained by the department from the office, including identifiable patient-level data or information, pursuant to RSA 318-B:34, is confidential, is not a public record or otherwise subject to disclosure under RSA 91-A, is not subject to discovery, subpoena, or other means of legal compulsion for release and shall not be shared with an agency or institution, except as provided in RSA 318-B:34, or under this section.</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">		III.  The department, in consultation with the office, may release reports for analysis and evaluation, statistical analysis, public research, public policy, and educational purposes, provided that the information and the data within the reports is aggregated or otherwise de-identified.  No individual whose identifiable patient-level data or information was provided by the office to the department shall be contacted, or subject to any action, by the department, directly or indirectly, on the basis of such data or information. </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">		IV.(a)  The department shall enter into one or more reciprocal data sharing agreements with the office to share prescription drug monitoring information for public health purposes including, but not limited to, public health evaluation, coordination of health care, and for the delivery of critical services to address substance use disorders.  The office shall receive any final analyses or reports made with shared data.  Any proposed data sharing agreement between the office and the department shall be reviewed by the advisory council for the controlled drug prescription health and safety program, established under RSA 318-B:38, which may make recommendations to the office.  The department may release studies with de-identified data, provided the release is authorized by the data sharing agreement.  The data sharing agreements shall include:</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">				(1)  The specific purpose of sharing data; </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">				(2)  A detailed description of the data sets that will be included; </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">				(3)  The criteria and procedures for the development of data sets;</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">				(4)  The criteria and procedures to ensure data security and destruction; and</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">				(5)  A proposed time frame in which the data will be used.</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">			(b)  Under no circumstances shall the data or information received by the department pursuant to this section be copied or released by the department to any other person or entity, unless the data or information is aggregated or otherwise de-identified.</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52"> </span><a name="Chapt3"></a><span class="csDD5E5F52">3  Controlled Drug Prescription Health and Safety Program; Definitions.  Amend RSA 318-B:31, IV to read as follows:</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">		IV.  "Dispenser" means a person or entity who is lawfully authorized to deliver a schedule II-IV controlled substance, </span><span class="cs22FF6315">and conduct medication reconciliation, </span><span class="csDD5E5F52">but does not include: </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">			(a)  A licensed hospital pharmacy </span><span class="cs22FF6315">under RSA 318 </span><span class="csDD5E5F52">that dispenses less than a 48-hour supply of a schedule II-IV controlled substance from a hospital emergency department or that dispenses for administration in the hospital; </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">			(b)  A practitioner, or other authorized person who administers such a substance; </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">			(c)  A wholesale distributor of a schedule II-IV controlled substance or its analog; </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">			(d)  A prescriber who dispenses less than a 48-hour supply of a schedule II-IV controlled substance from a hospital emergency department to a patient; [</span><span class="cs98AF35F2">or</span><span class="csDD5E5F52">] </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">			(e)  A veterinarian who dispenses less than a 48-hour supply of a schedule II-IV controlled substance to a patient</span><span class="cs22FF6315">; or</span><span class="csDD5E5F52"> </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="cs22FF6315">			(f)  A practitioner who neither prescribes nor dispenses and who is not actively working as a pharmacist within a New Hampshire licensed pharmacy licensed under RSA 318 or New Hampshire health care facility licensed under RSA 151</span><span class="csDD5E5F52">.</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52"> </span><a name="Chapt6"></a><span class="csDD5E5F52">4  Providing Controlled Drug Prescription Health and Safety Information.  Amend RSA 318-B:35, I(a)(2) and (3) to read as follows:</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">				(2)  For reviewing information regarding prescriptions issued or dispensed by the requester; [</span><span class="cs98AF35F2">or</span><span class="csDD5E5F52">] </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">				(3)  For the purpose of investigating the death of an individual</span><span class="cs22FF6315">; or</span><span class="csDD5E5F52"> </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">				(</span><span class="cs22FF6315">4)  For the purpose of administering RSA 318:29-a, VI, RSA 326-B:36-a, RSA 329:13-b, and other participating health professional boards</span><span class="csDD5E5F52">.</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52"> </span><a name="CHAPT"></a><span class="csDD5E5F52">5  New Paragraphs; Controlled Drug Prescription Health and Safety Program; Confidentiality.  Amend RSA 318-B:34 by inserting after paragraph III the following new paragraphs:</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">		IV.  The office may release identifiable patient-level data or information to the department of health and human services for public health purposes if the office authorizes the release of such data or information pursuant to a data sharing agreement between the office and the department.  Any such data sharing agreement shall be reviewed by the advisory council for the controlled drug prescription health and safety program established in RSA 318-B:38, which may make recommendations to the office.  The department may release studies with de-identified data, provided the release is authorized by the data sharing agreement.  The data sharing agreement shall include: </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">			(a)  The specific purpose of sharing data; </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">			(b)  A detailed description of the data sets that will be included; </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">			(c)  The criteria and procedures for the development of data sets; </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">			(d)  The criteria and procedures to ensure data security and destruction; and </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">			(e)  A proposed time frame in which the data will be used.  Under no circumstances shall the data or information released to the department pursuant to this section be copied or released by the department to any other person or entity, unless the data or information is aggregated or otherwise de-identified.  </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">		V.  The department of health and human services shall comply with RSA 318-B:32, III with respect to data or information received pursuant to paragraph IV.</span><span class="cs2C11128C"> </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52"> </span><a name="Chapt7"></a><span class="csDD5E5F52">6  Repeal.  RSA 318-B:35, I(b)(5), relative to a practitioner or consultant retained by the office of professional licensure and certification to review certain information, is repealed.</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52"> </span><a name="Chapt8"></a><span class="csDD5E5F52">7  Effective Date.  This act shall take effect upon its passage.</span></p></body>
</html>
